Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Gyn. Mottagning E. Svanborg AB
AB
Active
Org 5565296877
Centralvägen 17, 171 68
Solna
Medical specialists activities
·
NACE 8622
Est. 1996 · 30 years old
2 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
Gyn. Mottagning E. Svanborg AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
5M
4M
2M
1M
0M
2020: 4M
4M
2020
2021: 4M (0% vs 2020)
4M
0%
2021
2022: 4M (0% vs 2021)
4M
0%
2022
2023: 4M (0% vs 2022)
4M
0%
2023
2024: 4M (0% vs 2023)
4M
0%
2024
EBITDA
SEK millions
2M
2M
1M
1M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 1M
1M
2022
2023: 2M (+100% vs 2022)
2M
+100%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
4 112
4 216
3 803
3 916
3 670
Staff expenses
—
—
—
—
—
EBITDA
419
1 822
791
217
−48
Depreciation & amort.
−182
−190
−189
−189
−190
EBIT
237
1 632
602
28
−238
Net financials
769
668
−23
−21
−29
Profit before tax
1 126
3 783
478
6
68
Tax
−80
−672
−102
−4
−56
Net profit
1 046
3 111
376
2
12
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
5 986
6 586
6 185
5 817
6 791
Equity
4 282
4 219
2 058
2 381
3 079
Long-term debt
0
372
1 029
91
480
Short-term debt
492
663
284
629
517
Total debt
492
1 035
1 313
720
997
Financial ratios
5-year trend
EBITDA margin
10,2 %
This company
15,8 %
Market median
This company
Market median
35% below market
2020
2024
Equity ratio
71,5 %
This company
38,2 %
Market median
This company
Market median
87% above market
2020
2024
Return on equity
24,4 %
This company
18,4 %
Market median
This company
Market median
33% above market
2020
2024
Net profit margin
25,4 %
This company
8,1 %
Market median
This company
Market median
214% above market
2020
2024
Asset turnover
0,69×
This company
1,12×
Market median
This company
Market median
38% below market
2020
2024
Debt / equity
0,40×
This company
0,62×
Market median
This company
Market median
35% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Gyn. Mottagning E. Svanborg AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
